Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
- 2022-01-11
- RCT · n = 300
- Gut Microbes 14(1)
- P. Gutiérrez-Castrellón
- Tania Gandara-Martí
- A. T. Abreu y Abreu
- Cesar D. Nieto-Rufino
- E. López-Orduña
- I. Jiménez-Escobar
- C. Jiménez-Gutiérrez
- G. López-Velázquez
- Jordi Espadaler Mazo
- PubMed: 35014600
- DOI: 10.1080/19490976.2021.2018899
- High evidence
- Large Human Trial
- Highly Cited
- Rigorous Journal
- Clinical
Probiotic supplementation was well-tolerated and reduced nasopharyngeal viral load, lung infiltrates and duration of both digestive and non-digestive symptoms, compared to placebo.
- Effect
- Beneficial
- Effect size
- Moderate